Showing results filtered by:
82 Results
A collection of sample grant applications and other resources provided by NIAID investigators.
Last Reviewed: November 6, 2024
TBRS is a multidisciplinary group composed of chemists, microbiologists, veterinarians, imaging scientists, and clinicians with a shared objective of improving chemotherapy for tuberculosis (TB) patients. Projects span chemical biology, medicinal chemistry, host-pathogen interactions, animal models of experimental chemotherapy, and experimental medicine clinical studies in TB patients.
Last Reviewed: March 11, 2025
This page covers NIAID Human Subjects Resources. Table of Contents General Human Subjects Planning a Human Subjects Application Planning an Investigator-Initiated Clinical Trial Human Subjects Documentation Human Subjects Research Plan Data Sharing Plan Human Subjects Protocol Data and Safety Monitoring Plan Phase III Clinical Trials Target Study Enrollment IND or IDE Requirements rDNA
Last Reviewed: August 30, 2019
Here NIH offers information to help you determine whether your research is considered human subjects and how to comply with regulations at all phases.
Last Reviewed: November 18, 2024
NBBTP/IRTA Fellows are trained specifically to support high containment research environments. Upon graduating from the program, NBBTP/IRTA alumni begin work as biorisk professionals with the knowledge and skills necessary to meet the scientific, regulatory, biocontainment, biosafety, engineering, communications, management, and public relations challenges associated with the conduct of research
Last Reviewed: January 21, 2025
The 202nd meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened virtually at 10:30 a.m. on Monday, September 12, 2022. Dr. Anthony S. Fauci, Director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was open to the public from 10:30 a.m. to 11:44 a.m. and from 1
Last Reviewed: January 27, 2023
The 205 th meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened at 5601 Fishers Lane in the Grand Hall at 10:30 a.m. on Monday, September 11, 2023. Dr. Hugh Auchincloss, Acting Director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was open to the public
Last Reviewed: January 11, 2024